Abstract
Iron overload (IO) affected the survival of patients with myelodysplastic syndrome (MDS). Deferasirox (DFX) is widely used in patients with MDS for iron chelation therapy, but is not suitable for...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have